Biblioteca GAMZU
/14_Material Extra 8/PGG/tig.org.za
⬅ Volver
📄 PDFs
01businessday_16_2_06.pdf
0.2 MB
1.AZT_prioritized_as_being_'of_High_Carcinogenicity_Concern'_October_2003.pdf
0.1 MB
2.AZT_on_draft_priority_list_October_2003.pdf
0.3 MB
3.AIDS_activists'_first_attempt to_stop_classification_of_AZT_as_known_carcinogen_3_December_2003.pdf
0.5 MB
4.Request_for_comments_before_listing_AZT_as_carcinogen_12_June_2009.pdf
0.1 MB
5.AIDS_activists'_second_attempt to_stop_classification_of_AZT_as_known_carcinogen_12_July_2009.pdf
0.1 MB
6.AZT_listed_as_a_chemical_known_to_the_state_of_California_to_cause_cancer_or_reproductive_toxicity_18_December_2009.pdf
0.6 MB
65 Back expert report on AZT triphosphorylation.pdf
1 MB
67A Lavie et al Bottleneck in AZT Activation.pdf
0.4 MB
67B Blakeslee on AZT triphosphorylation.pdf
0.7 MB
68 Back's drug industry funding per his CV.pdf
0.1 MB
Achmat Eng colour.pdf
0.2 MB
Address_to_NCOP.pdf
0.2 MB
asa_ruling.pdf
1.4 MB
azt-achmat_geffen_heywood.pdf
0.1 MB
azt-mbeki_tshabalala-msimang.pdf
0.1 MB
AZTdata.pdf
0.1 MB
AZTflyer-isiZulu.pdf
0.3 MB
AZTflyer-isiXhosa.pdf
0.2 MB
AZT_flyer_Setswana.pdf
0 MB
azt_nevirapine_small.pdf
2 MB
azt_pharmacology.pdf
0.4 MB
backcover.pdf
0 MB
Bonn.pdf
0 MB
BRINK AFFIDAVIT WITH ANNEXURES HYPERLINKED AND TYPO FIXES.pdf
0.5 MB
Brink_the_liar.pdf
0.1 MB
Chaskalson.pdf
0.1 MB
CR.Child_mortality_summary_ Jan_16.pdf
0.1 MB
CR.HSRC_and_StatsSA_sex_differences.pdf
0 MB
Critical_Analysis_of_Child_HIV_Prevalence.pdf
0 MB
Critical_Analysis_of_the_Underlying_Assumptions_Used_by_Chigwedere_et_al.pdf
0.1 MB
CR_Mercury_letter_4_Dec_15.pdf
0.8 MB
CR_Statistics_May_2015.pdf
0.1 MB
debating_azt.pdf
1.2 MB
Deconstructing_Duesberg (1).pdf
0 MB
ENV_Commentary.pdf
1.2 MB
expert_verification_statement.pdf
0.1 MB
Heads of Argument.pdf
0 MB
Heyns.pdf
0.1 MB
icc_achmatcomplaint.pdf
0.1 MB
icc_ncube letter.pdf
0 MB
icc_ncube_ annexures.pdf
0 MB
icc_serviceconfirmationletter.pdf
0.7 MB
Introducing_AZT.pdf
0.9 MB
Introducing_AZT (1).pdf
0.9 MB
Inventing_AZT.pdf
0.1 MB
Inventing_AZT (1).pdf
0.1 MB
jsy_frontcoverconcept.pdf
1 MB
JSY_prospectus_A5_booklet.pdf
0.8 MB
judith-miller-award.pdf
0 MB
Kahn.pdf
0 MB
Karabus.pdf
0 MB
letter_devos.pdf
0 MB
Licensing_AZT (1).pdf
0.2 MB
Licensing_AZT.pdf
0.2 MB
mail&guardian_18_11_05.pdf
0.1 MB
Mbeki Eng new.pdf
0.8 MB
MCC.pdf
0.2 MB
media_complicity.pdf
0.1 MB
MEGA TV letter.pdf
0.2 MB
mhlongo_affidavit.pdf
0 MB
MTM letter.pdf
0.2 MB
Nevirapine_plugs_in_The_Constant_Gardener_movie.pdf
0 MB
nevppsn1.pdf
1.2 MB
nla.oh-2815-0080_Eleni Papadopulos-Eleopulos and Valendar Turner.pdf
0.4 MB
openletter_gsk.pdf
0 MB
P65single072911.pdf
0.5 MB
Perfectly_true_actually.pdf
0 MB
PG_Back_rebuttal.pdf
0.1 MB
PoC (1).pdf
1.2 MB
PoC.pdf
1.2 MB
Press statement with press kit covering note.pdf
0.2 MB
request-to-prof-eagles.pdf
0 MB
Shapiro.pdf
0.3 MB
Shisana.pdf
0.1 MB
Shisana2.pdf
0 MB
sundaytimes_19_2_06.pdf
0.1 MB
The trouble with nevirapine.pdf
1 MB
The trouble with nevirapine (1).pdf
1 MB
TIG_PRESS_STATEMENT_AZT_in_pregnancy.pdf
0 MB
tig_response_to_asa.pdf
0.2 MB
TIG_to_ASA_reminder.pdf
0.1 MB
Transparency_and_Conservative_Values_in_Chigwedere_et_al..pdf
0 MB
Venter.pdf
0 MB
what_killed_makgatho_mandela.pdf
0.1 MB
Who_s_the_buffoon.pdf
0 MB
zokufa.pdf
0 MB
📦 Otros
download.htm
0.1 MB